The Association Between Biomarkers and Neuropsychiatric Symptoms Across the Alzheimer's Disease Spectrum

Autor: Banning, L.C.P., Ramakers, I.H.G.B., Kohler, S., Bron, E.E., Verhey, F.R.J., Deyn, P.P. de, Claassen, J.A.H.R., Koek, H.L., Middelkoop, H.A.M., Flier, W.M. van der, Lugt, A. van der, Aalten, P., Alzheimers Dis Neuroimaging Initia, Parelsnoer Inst Neurodegenerative

Publikováno v: American journal of geriatric psychiatry
American Journal of Geriatric Psychiatry, 28, 735-744
American Journal of Geriatric Psychiatry, 28, 7, pp. 735-744
American Journal of Geriatric Psychiatry, 28(7), 735-744. ELSEVIER SCIENCE INC
Banning, L C P, Ramakers, I H G B, Köhler, S, Bron, E E, Verhey, F R J, de Deyn, P P, Claassen, J A H R, Koek, H L, Middelkoop, H A M, van der Flier, W M, van der Lugt, A, Aalten, P, The Alzheimer's Disease Neuroimaging Initiative & Parelsnoer Institute Neurodegenerative Diseases study group 2020, ' The Association Between Biomarkers and Neuropsychiatric Symptoms Across the Alzheimer's Disease Spectrum ', American Journal of Geriatric Psychiatry, vol. 28, no. 7, pp. 735-744 . https://doi.org/10.1016/j.jagp.2020.01.012
American Journal of Geriatric Psychiatry, 28(7), 735-744. Lippincott Williams and Wilkins
American Journal of Geriatric Psychiatry, 28(7), 735-744. Elsevier Science
American Journal of Geriatric Psychiatry, 28(7), 735-744. Elsevier Inc.

Objective: To investigate the relationship between Alzheimer's disease biomarkers and neuropsychiatric symptoms. Methods: Data from two large cohort studies, the Dutch Parelsnoer Institute – Neurodegenerative Diseases and the Alzheimer's Disease Ne

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ee989bad73fcf06a9f2841c40505b51
https://doi.org/10.1016/j.jagp.2020.01.012